← back to search

Ruihui Xie

Sun Yat-sen University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer-related molecular mechanisms research, and RNA Research and Splicing.
h-index
19
citations
2,264
works
68
NIH funding
primary concept
email

Recent publications

Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer
International Journal of Biological Sciences 2024cited by 24position: middledoi
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer
Advanced Science 2024cited by 14position: middledoi
Oncogenic <i>SLC2A11–MIF</i> fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability
MedComm 2024cited by 13position: middledoi
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
Cancer Research 2023cited by 184position: firstdoi
ETV4 Mediated Tumor‐Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer
Advanced Science 2023cited by 118position: middledoi
TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination
Journal of Experimental & Clinical Cancer Research 2023cited by 30position: middledoi
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program
Cancer Communications 2022cited by 116position: middledoi
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
Journal of Experimental & Clinical Cancer Research 2021cited by 96position: middledoi
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer
Theranostics 2021cited by 86position: middledoi
Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
Journal of Clinical Investigation 2020cited by 257position: middledoi
NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR
Molecular Therapy 2020cited by 91position: firstdoi
Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis
Molecular Cancer 2019cited by 195position: middledoi
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer
Molecular Cancer 2019cited by 151position: middledoi
DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression
Molecular Therapy 2019cited by 142position: middledoi
Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM
Cancer Letters 2019cited by 102position: firstdoi
Long Noncoding RNA <i>LBCS</i> Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2
Clinical Cancer Research 2018cited by 215position: middledoi
lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5
Molecular Therapy 2017cited by 213position: middledoi
Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer
Journal of Cellular and Molecular Medicine 2016cited by 103position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xu Chen · University of Southern California16 papers (2016–2024)Tianxin Lin · State Key Laboratory of Oncology in South China13 papers (2017–2023)Ming Huang · Tianjin University of Traditional Chinese Medicine12 papers (2018–2024)Jian Huang · Zunyi Medical University10 papers (2016–2023)Qianghua Zhou · University Health Network9 papers (2019–2023)Jinli Han · Zhejiang Normal University7 papers (2016–2021)Jingtong Zhang · Sun Yat-sen University6 papers (2019–2021)Ziyue Chen · Qingdao Agricultural University6 papers (2017–2023)Shengmeng Peng · Sun Yat-sen University6 papers (2020–2024)Jian Huang · Harbin Medical University4 papers (2020–2024)Wen Dong · Yunnan Normal University4 papers (2017–2020)Wen Dong · Yunnan Normal University4 papers (2019–2022)Weibin Xie · Sun Yat-sen University4 papers (2016–2019)Yuelong Chen · Chinese University of Hong Kong3 papers (2020–2022)Liang Cheng · Bengbu Medical College3 papers (2020–2023)Haixia He · Multimeric Biotherapeutics (United States)3 papers (2021–2024)Peng Gu · Army Medical University3 papers (2017–2019)Siting Chen · Fujian Medical University3 papers (2022–2024)Junlin Lu · Sun Yat-sen University2 papers (2023–2023)Hongjin Wang · Dalian Medical University2 papers (2023–2023)